TREA

98391336 - REGENSKIN

Follow

Information

  • Trademark
  • 98391336
  • Serial Number
    98391336
  • Filing Date
    February 05, 2024
    9 months ago
  • Transaction Date
    October 30, 2024
    23 days ago
  • Status Date
    October 29, 2024
    24 days ago
  • Published for Opposition Date
    November 19, 2024
    3 days ago
  • Location Date
    October 29, 2024
    24 days ago
  • Status Code
    681
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    HELLMAN, ELI
  • Attorney Name
    Lindsay H. Kaplan
    Law Office Assigned Location Code
    L20
  • Owners
Information
Mark Drawing Code
4
Mark Identification
REGENSKIN
Case File Statements
  • GS0051: Biological preparations for the treatment of wounds, damaged tissue, scars, and skin wrinkles, namely, platelet concentrate, platelet rich plasma, platelet poor plasma, fibrin gel, platelet rich fibrin, cell extracts, cell concentrates, stem cells, hyaluronic acid, silk, chitosan or any combinations thereof; such goods not including implantable medical devices for use in the regeneration of natural tissue
  • PM0001: REGEN SKIN
  • GS0441: medical services, namely, treatments using platelet rich plasma, platelet poor plasma, platelet rich fibrin, blood platelet concentrate, platelet fibrin gel, white blood cells, buffy coat, stem cells, and other blood related extracts or any combination of blood contents in the field of tissue and cellular enhancement, repair, reconstruction, regeneration and rejuvenation, regenerative medicine; medical services, namely, treatments using platelet rich plasma, platelet poor plasma, platelet rich fibrin, blood platelet concentrate, platelet fibrin gel, white blood cells, buffy coat, stem cells, and other blood related extracts or any combination of blood contents in the field of blood or bone marrow related components including platelets, plasma concentrates, thrombin serum and stem cells, to mesotherapy, to hyaluronic acid, chitosan or silk, to the isolation, application, micro-needling and/or injection of a patient's own platelets, thrombin serum and/or cells alone or in combination with any other substance including cell extract or cell extracts, stem cells, hyaluronic acid, silk, or chitosan; Providing medical, veterinary and surgical information in the field of tissue and cellular regeneration and rejuvenation, regenerative medicine, isolation and application of a patient's own platelets and cells via the Internet; providing healthcare consultancy and advice for business executives, health care workers, health care specialists, medical doctors and patients in the fields of cellular and tissue regeneration, regenerative medicine, rejuvenation, as well as isolating, treating and injecting blood platelets or cells into patients
  • GS0101: Medical kits comprised primarily of blood collecting tubes, syringes for medical purposes, needles for medical use, connectors for attaching blood collection tubes, centrifuges, syringes, and injection apparatus, nozzles for dispensing biological preparations, stoppers for the sealing of tubes and vials, adapters for connecting syringes to blood collection tubes, transfer devices for the transfer of biological preparations, also including thixotropic gels, anticoagulants, coagulation activating preparations, and hyaluronic acid for pharmaceutical purposes, the aforementioned medical kits intended for the preparation of platelet concentrate, platelet rich plasma, platelet poor plasma, fibrin gel, platelet rich fibrin, cell extracts, cell concentrates, stem cells, hyaluronic acid, silk, chitosan or any combinations thereof; medical kits intended for tissue and cellular regeneration, rejuvenation, healing and repair comprised of receptacles, namely blood collecting and sampling tubes, vials, jars, bags, pouches, cartridges, bottles, cylinders or pods for blood testing apparatus, medical syringes and needles, the aforementioned for regenerative medicine, isolation and application of platelets and cells, for example from blood, fat, bone marrow, stem cells and other tissue; and medical kits comprising blood collecting and sampling tubes for blood testing apparatus, and medical syringes and needles for regenerative medicine, the aforementioned kits for the preparation of a platelet concentrate, the isolation and application of platelets and cells, for example from blood, fat, bone marrow, stem cells and other tissue; such goods not including implantable medical devices for use in the regeneration of natural tissue.
  • GS0421: research services, namely, scientific research studies, in the field of tissue and cellular regeneration and rejuvenation, regenerative medicine, isolation and application of a patient's own platelets and cells; Electronic storage services in the nature of database management, namely, electronic storage of business records of others
Case File Event Statements
  • 2/5/2024 - 9 months ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 6/2/2024 - 5 months ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 8/28/2024 - 2 months ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 9/5/2024 - 2 months ago
    8 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 9/5/2024 - 2 months ago
    9 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 9/9/2024 - 2 months ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 9/9/2024 - 2 months ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 10/23/2024 - a month ago
    13 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 10/23/2024 - a month ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 10/23/2024 - a month ago
    12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 10/23/2024 - a month ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 9/9/2024 - 2 months ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 9/5/2024 - 2 months ago
    7 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR